Samsa1, do you have any idea when Focalin will be approved for additional doses?
I would say when everybody loses confidence, it's time to buy. I do agree with some of your points. However, they may get more approval since there is a deadline on the FDA generic drug approval. Plus, a new NDA will be filed soon.
If dilution, it will be after the NDA filing. If the price goes up to above $4, it is a pretty good deal.
The cash is that low, apparently they have a plan for funding. Partnership announcement soon. Buy.
The target was $5 and reached one time after the first approval. The new target was raised to above $8 after the removal of phase III requirement by FDA, and has not reached yet.
It's understandable that share price drops after the earning announcement. It will come back once people realize there is a plan for financing.
Agree. I think the management has a plan for financing when the cash reaches that low level. Either a co-development with cash incoming, or a loan from the management themselves as they did before, or great news that they can do ATM, is possible. Otherwise, the cash should not reach that low before refiancing.